Previous 10 | Next 10 |
Tivity Health (NASDAQ: TVTY ) -39% on Q4 earnings . More news on: Tivity Health, Inc., Six Flags Entertainment Corporation, BioXcel Therapeutics, Inc., Stocks on the move, Read more ...
Invitae (NYSE: NVTA ) slumps 9% premarket on light volume on the heels of its Q4 results which came in shy of expectations. More news on: Invitae Corporation, Healthcare stocks news, Stocks on the move, Earnings news and commentary, , Read more ...
SAN FRANCISCO , Feb. 20, 2020 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that Sean George , co-founder and chief executive officer of Invitae, will present at the 9th Annual SVB Leerink Global Healthcare Conference on Tue...
Image source: The Motley Fool. Invitae Corp (NYSE: NVTA) Q4 2019 Earnings Call Feb 19, 2020 , 4:30 p.m. ET Operator Continue reading
Invitae Corporation (NVTA) Q4 2019 Results Earnings Conference Call February 19, 2020 04:30 PM ET Company Participants Laura D'Angelo - Head of Investor Relations Sean George - CEO Shelly Guyer - CFO Lee Bandekgey - COO Bob Nussbaum - Chief Medical Officer Katherine Stuelan...
Invitae (NYSE: NVTA ): Q4 Non-GAAP EPS of -$0.63; GAAP EPS of -$0.79 misses by $0.07 . More news on: Invitae Corporation, Earnings news and commentary, Stocks on the move, Healthcare stocks news, Read more ...
SAN FRANCISCO , Feb. 19, 2020 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced financial and operating results for the fourth quarter and full year ended December 31, 2019. "In 2019, we delivered another year of extr...
Invitae (NYSE: NVTA ) is scheduled to announce Q4 earnings results on Wednesday, February 19th, after market close. The consensus EPS Estimate is -$0.72 (-80.0% Y/Y) and the consensus Revenue Estimate is $66.62M (+46.9% Y/Y). Over the last 2 years, NVTA has beaten EPS estimates 38% o...
Molecular testing services provider Invitae ( NVTA +18.5% ) jumps on almost triple normal volume in apparent response to a recommendation in Motley Fool's Stock Advisor (paywalled). More news on: Invitae Corporation, Healthcare stocks news, Stocks on the move, Read more ...
This article was highlighted for PRO+ subscribers, Seeking Alpha’s service for professional investors. Find out how you can get the best content on Seeking Alpha here . 2019 was difficult for short-sellers considering what ended up being a historically strong year for the...
News, Short Squeeze, Breakout and More Instantly...
Labcorp Announces Winning Bid for Select Assets of Invitae PR Newswire Advances Labcorp strategy to launch and scale specialty testing in areas such as oncology and rare diseases Transaction requires court approval, with confirmation expected on May 6, 2024 ...
Invitae Enters into Agreement with Labcorp for Sale of Business PR Newswire – Labcorp Selected as Winning Bidder in Court-Supervised Sale Process, Subject to Court and Regulatory Approvals – – $239 Million Cash Bid Includes Acquisition of Substantial...
Invitae Unveils New Research for Breast Cancer Patients with Variants of Uncertain Significance PR Newswire – Study findings to be presented at the 2024 American Society of Breast Surgeons Annual Meeting – SAN FRANCISCO , April 11, 2024 /PRNewsw...